The fate of indeterminate liver lesions: What proportion are precursors of hepatocellular carcinoma?
- PMID: 35272611
- PMCID: PMC8908619
- DOI: 10.1186/s12876-022-02135-x
The fate of indeterminate liver lesions: What proportion are precursors of hepatocellular carcinoma?
Abstract
Background: The natural history and incidence of hepatocellular carcinoma (HCC) arising from indeterminate liver lesions are not well described. We aimed to define the incidence of HCC in a cohort of patients undergoing surveillance by magnetic resonance imaging (MRI) and estimate any associations with incident HCC.
Methods: We performed a retrospective follow-up study, identifying MRI scans in which indeterminate lesions had been reported between January 2006 and January 2017. Subsequent MRI scan reports were reviewed for incident HCC arising from indeterminate lesions, data were extracted from electronic patient records and survival analysis performed to estimate associations with baseline factors.
Results: One hundred and nine patients with indeterminate lesions on MRI were identified. HCC developed in 19 (17%) patients over mean follow up of 4.6 years. Univariate Cox proportional hazards analysis found incident HCC to be significantly associated with baseline low platelet count (hazard ratio (HR) = 7.3 (95% confidence intervals (CI) 2.1-24.9), high serum alpha-fetoprotein level (HR = 2.7 (95% CI 1.0-7.1)) and alcohol consumption above fourteen units weekly (HR = 3.1 (95% CI 1.1-8.7)). Multivariate analysis, however, found that only low platelet count was independently associated with HCC (HR = 5.5 (95% CI 0.6-5.1)).
Conclusions: HCC arises in approximately one fifth of indeterminate liver lesions over 4.6 years and is associated with a low platelet count at the time of first diagnosis of an indeterminate lesion. Incidence of HCC was more common in people with viral hepatitis and in those consuming > 14 units of alcohol per week. Our data may be used to support a strategy of enhanced surveillance in patients with indeterminate lesions.
Keywords: Hepatocellular carcinoma; Liver cirrhosis; Liver neoplasms; Magnetic resonance imaging.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Risk of Malignancy in Indeterminate Liver Nodules Among Patients with Cirrhosis: A Retrospective Cohort Study.J Gastrointest Cancer. 2024 Oct 16;56(1):1. doi: 10.1007/s12029-024-01122-7. J Gastrointest Cancer. 2024. PMID: 39414724 Free PMC article.
-
Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.Am J Gastroenterol. 2017 Mar;112(3):460-470. doi: 10.1038/ajg.2016.480. Epub 2016 Oct 25. Am J Gastroenterol. 2017. PMID: 27779194
-
Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B.Clin Mol Hepatol. 2019 Dec;25(4):390-399. doi: 10.3350/cmh.2018.0103. Epub 2019 May 31. Clin Mol Hepatol. 2019. PMID: 31146508 Free PMC article.
-
Evolution of indeterminate hepatocellular nodules at Gd-EOB-DPTA-enhanced MRI in cirrhotic patients.Radiol Med. 2018 Jul;123(7):489-497. doi: 10.1007/s11547-018-0873-8. Epub 2018 Mar 15. Radiol Med. 2018. PMID: 29546493
-
An indeterminate nodule in the cirrhotic liver discovered by surveillance imaging is a prelude to malignancy.J Surg Oncol. 2014 Dec;110(8):967-9. doi: 10.1002/jso.23765. Epub 2014 Aug 25. J Surg Oncol. 2014. PMID: 25155168 Free PMC article.
Cited by
-
Risk of Malignancy in Indeterminate Liver Nodules Among Patients with Cirrhosis: A Retrospective Cohort Study.J Gastrointest Cancer. 2024 Oct 16;56(1):1. doi: 10.1007/s12029-024-01122-7. J Gastrointest Cancer. 2024. PMID: 39414724 Free PMC article.
-
Cost-effectiveness analysis of artificial intelligence (AI) in earlier detection of liver lesions in cirrhotic patients at risk of hepatocellular carcinoma in Italy.J Med Econ. 2025 Dec;28(1):1023-1036. doi: 10.1080/13696998.2025.2525006. Epub 2025 Jul 11. J Med Econ. 2025. PMID: 40586549 Free PMC article.
References
-
- Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, Al-Raddadi R, Alvis-Guzman N, Amoako Y, Artaman A, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015. JAMA Oncol. 2017;3:1683–1691. doi: 10.1001/jamaoncol.2017.3055. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical